tag:blogger.com,1999:blog-2546008714740235720.post7169479080620335347..comments2024-03-25T07:19:52.909+00:00Comments on The ChEMBL-og: What is the R&D Cost of a New Medicine?Unknownnoreply@blogger.comBlogger1125tag:blogger.com,1999:blog-2546008714740235720.post-13542246487067213752013-08-13T10:24:33.417+01:002013-08-13T10:24:33.417+01:00The more I think about this number the more diffic...The more I think about this number the more difficult it gets to quantify - Pharma run a business making profits for shareholders - optimising profits, and not a business optimizing NME output. Many/most trials that a drug company run will be expanding the indications for a previously approved NME - check out the pipeline documents for some of the big companies to get an idea of just how many. These costs will be big (since they are trials), but will appear to dilute the per NME output. In fact a perfect business, would probably not innovate and rely on finding new indications for previously launched safe pharmaceuticals.....jpohttps://www.blogger.com/profile/11392161215016795205noreply@blogger.com